First evidence of melatonin receptors distribution in the suprachiasmatic nucleus of tree shrew brain

Neuroendocrinology Letters

Volumn 28, Issue 3, 2007, Pages 267-273

  Legros, Céline ^a,b,c,d   Chalivoix, Stéphanie ^a,b,c,d   Gabriel, Cecilia ^e   Mocaer, Elisabeth ^e   Delagrange, Philippe ^f   Fuchs, Eberhard ^g   Malpaux, Benoît ^a,b,c,d  

^a UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d Haras Natioanaux   (France)

^e INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^f INSTITUT DE RECHERCHES SERVIER   (France)

^g GERMAN PRIMATE CENTER   (Germany)

Author keywords

2 125I MLT; Agomelatine; Autoradiography; Melatonergic receptor; Melatonin; Tree shrew

Indexed keywords

2 IODOMELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BEHAVIORAL STRESS; BINDING SITE; BIOLOGICAL RHYTHM; BRAIN TISSUE; CAUDATE NUCLEUS; CEREBELLUM; CIRCADIAN RHYTHM; CORTICAL SYNCHRONIZATION; DEPRESSION; DOPAMINERGIC SYSTEM; FEMALE; HIPPOCAMPUS; HYPOPHYSIS PARS TUBERALIS; LIGAND BINDING; MENTAL STRESS; MODULATION; MOOD; NEUROENDOCRINE DISEASE; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PUTAMEN; SCANDENTIA; SUPRACHIASMATIC NUCLEUS; VALIDATION PROCESS;

EID: 34447279056     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Audinot, V., F. Mailliet, C. Lahaye-Brasseur, A. Bonnaud, A. Le Gall, C. Amosse, S. Dromaint, M. Rodriguez, N. Nagel, J.P. Galizzi, B. Malpaux, G. Guillaumet, D. Lesieur, F. Lefoulon, P. Renard, P. Delagrange, and J.A. Boutin, New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2003; 367(6): 553-61.
2. Millan, M.J., A. Gobert, F. Lejeune, A. Dekeyne, A. Newman-Tancredi, V. Pasteau, J.M. Rivet, and D. Cussac, The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther. 2003; 306(3): 954-64.
3. Papp, M., P. Gruca, P.A. Boyer, and E. Mocaer, Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology. 2003; 28(4): 694-703.
4. Bourin, M., E. Mocaer, and R. Porsolt, Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci. 2004; 29(2): 126-33.
5. Barden, N., E. Shink, M. Labbe, R. Vacher, J. Rochford, and E. Mocaer, Antidepressant action of agomelatine (S 20098) in a transgenic mouse model. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29(6): 908-16.
6. Bertaina-Anglade, V., C. Drieu-La-Rochelle, P.A. Boyer, and E. Mocaer, Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model. Behav Pharmacol. in press.
7. Loo, H., A. Hale, and H. D'Haenen, Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol. 2002; 17(5): 239-47.
8. Kennedy, S.H. and R. Emsley, Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol. 2006; 16(2): 93-100.
9. Rouillon, F., Efficacy and tolerance profile of agomelatine and practical use in depressed patients. Int Clin Psychopharmacol. 2006; 21(Suppl 1): S31-5.
10. Wehr, T.A. and A. Wirz-Justice, Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatria. 1982; 15(1): 31-9.
11. Tuma, J., J.H. Strubbe, E. Mocaer, and J.M. Koolhaas, Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN. Eur Neuropsychopharmacol. 2005; 15(5): 545-55.
12. Fuchs, E., M. Kramer, B. Hermes, P. Netter, and C. Hiemke, Psychosocial stress in tree shrews: clomipramine counteracts behavioral and endocrine changes. Pharmacol Biochem Behav. 1996; 54(1): 219-28.
13. Fuchs, E. and G. Flugge, Social stress in tree shrews: effects on physiology, brain function, and behavior of subordinate individuals. Pharmacol Biochem Behav. 2002; 73(1): 247-58.
14. Fuchs, E., B. Schmelting, and E. Mocaer, Effects of the novel antidepressant agomelatine (S 20098) and fluoxetine in chronically stressed tree shrews, an animal model of depression. Eur Neuropsychopharmacol. 2006; 16 (suppl 4): S338.
15. Fuchs, E., UFAW handbook on the care and management of laboratory animals. 7th Ed. Poole, T. ed. Vol. 1, Oxford: Blackwell. 1999.
16. Malpaux, B., A. Daveau, F. Maurice-Mandon, G. Duarte, and P. Chemineau, Evidence that melatonin acts in the premammillary hypothalamic area to control reproduction in the ewe: presence of binding sites and stimulation of luteinizing hormone secretion by in situ microimplant delivery. Endocrinology. 1998; 139(4): 1508-16.
17. Kluver, H. and E. Barrera, A method for the combined staining of cells and fibers in the nervous system. J Neuropathol Exp Neurol. 1953; 12(4): 400-3.
18. Tigges, J. and T.R. Shantha, A stereotaxic brain atlas of the tree shrew (Tupaia glis). Williams & Wilkins edBaltimore. 1969.
19. Paxinos, G. and C. Watson, The Rat Brain in Stereotaxic Coordinates. Academic Press edSydney. 1982.
20. 125I-brain paste standards for use in quantitative receptor autoradiography. J Neurosci Methods. 1989; 30(3): 247-53.
21. Poirel, V.J., C. Cailotto, D. Streicher, P. Pevet, M. Masson-Pevet, and F. Gauer, MT1 melatonin receptor mRNA tissular localization by PCR amplification. Neuro Endocrinol Lett. 2003; 24(1-2): 33-8.
22. Vanecek, J., A. Pavlik, and H. Illnerova, Hypothalamic melatonin receptor sites revealed by autoradiography. Brain Res. 1987; 435(1-2): 359-62.
23. Hunt, A.E., W.M. Al-Ghoul, M.U. Gillette, and M.L. Dubocovich, Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol. 2001; 280(1): C110-8.
24. Morgan, P.J., P. Barrett, H.E. Howell, and R. Helliwell, Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int. 1994; 24(2): 101-46.
25. Liu, C., D.R. Weaver, X. Jin, L.P. Shearman, R.L. Pieschl, V.K. Gribkoff, and S.M. Reppert, Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron. 1997; 19(1): 91-102.
26. Weaver, D.R. and S.M. Reppert, The Mella melatonin receptor gene is expressed in human suprachiasmatic nuclei. Neuroreport. 1996; 8(1): 109-12.
27. (125)I]iodomelatonin binding and MT1 gene expression. J Pineal Res. 2002; 33(4): 218-24.
28. Nonno, R., S. Capsoni, V. Lucini, M. Moller, F. Fraschini, and B. Stankov, Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates. J Pineal Res. 1995; 18(4): 207-16.
29. Williams, L.M., L.T. Hannah, C.E. Kyle, and C.L. Adam, Central melatonin receptors in red deer (Cervus elaphus). Gen Comp Endocrinol. 1996; 104(1): 1-6.
30. Williams, L.M., L.T. Hannah, M.H. Hastings, and E.S. Maywood, Melatonin receptors in the rat brain and pituitary. J Pineal Res. 1995; 19(4): 173-7.
31. Gauer, F., M. Masson-Pevet, D.J. Skene, B. Vivien-Roels, and P. Pevet, Daily rhythms of melatonin binding sites in the rat pars tuberalis and suprachiasmatic nuclei; evidence for a regulation of melatonin receptors by melatonin itself. Neuroendocrinology. 1993; 57(1): 120-6.
32. Piketty, V. and J. Pelletier, Melatonin receptors in the lamb pars tuberalis/median eminence throughout the day. Neuroendocrinology. 1993; 58(3): 359-65.
33. Reuss, S. and E. Fuchs, Anterograde tracing of retinal afferents to the tree shrew hypothalamus and raphe. Brain Res. 2000; 874(1): 66-74.
34. Redman, J.R. and A.J. Francis, Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal. J Biol Rhythms. 1998; 13(1): 39-51.
35. Fauteck, J.D., A. Lerchl, M. Bergmann, M. Moller, F. Fraschini, W. Wittkowski, and B. Stankov, The adult human cerebellum is a target of the neuroendocrine system involved in the circadian timing. Neurosci Lett. 1994; 179(1-2): 60-4.
36. Al-Ghoul, W.M., M.D. Herman, and M.L. Dubocovich, Melatonin receptor subtype expression in human cerebellum. Neuroreport. 1998; 9(18): 4063-8.
37. Williams, L.M., L.T. Hannah, and J.M. Bassett, Melatonin receptors in neonatal pig brain and pituitary gland. J Pineal Res. 1999; 26(1): 43-9.
38. Konarski, J.Z., R.S. McIntyre, L.A. Grupp, and S.H. Kennedy, Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? J Psychiatry Neurosci. 2005; 30(3): 178-86.
39. Schutter, D.J. and J. van Honk, A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression. J Psychiatry Neurosci. 2005; 30(2): 91-7.
40. Uz, T., A.D. Arslan, M. Kurtuncu, M. Imbesi, M. Akhisaroglu, Y. Dwivedi, G.N. Pandey, and H. Manev, The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res. 2005; 136(1-2): 45-53.
41. Stankov, B., B. Cozzi, V. Lucini, S. Capsoni, J. Fauteck, P. Fumagalli, and F. Fraschini, Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding. Neurosci Lett. 1991; 133(1):68-72.
42. Anis, Y. and N. Zisapel, Castration affects brain iodomelatonin binding in hamsters maintained in long but not short days. Mol Cell Endocrinol. 1991; 76(1-3): 23-34.
43. Mazzucchelli, C., M. Pannacci, R. Nonno, V. Lucini, F. Fraschini, and B.M. Stankov, The melatonin receptor in the human brain: cloning experiments and distribution studies. Brain Res Mol Brain Res. 1996; 39(1-2): 117-26.
44. Czeh, B., T. Michaelis, T. Watanabe, J. Frahm, G. de Biurrun, M. van Kampen, A. Bartolomucci, and E. Fuchs, Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A. 2001; 98(22): 12796-801.
45. El-Sherif, Y., M.V. Hogan, J. Tesoriero, and A. Wieraszko, Factors regulating the influence of melatonin on hippocampal evoked potentials: comparative studies on different strains of mice. Brain Res. 2002; 945(2): 191-201.
46. Argyriou, A., H. Prast, and A. Philippu, Melatonin facilitates short-term memory. Eur J Pharmacol. 1998; 349(2-3): 159-62.
47. Savaskan, E., G. Olivieri, F. Meier, L. Brydon, R. Jockers, R. Ravid, A. Wirz-Justice, and F. Muller-Spahn, Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients. J Pineal Res. 2002; 32(1): 59-62.
48. Savaskan, E., M.A. Ayoub, R. Ravid, D. Angeloni, F. Fraschini, F. Meier, A. Eckert, F. Muller-Spahn, and R. Jockers, Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. J Pineal Res. 2005; 38(1): 10-6.
49. Larson, J., R.E. Jessen, T. Uz, A.D. Arslan, M. Kurtuncu, M. Imbesi, and H. Manev, Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice. Neurosci Lett. 2006; 393(1): 23-6.
50. Esposito, E., Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr Drug Targets. 2006; 7(2): 177-85.